matt mindset pre-announce result sale
xfx organ vs consensu ep expect
high end guidanc consensu
top-lin result beat consensu across segment medsurg
strongest outperform follow ortho neurotech
spine instal mako robot global
system field upgrad total knee applic us knee sale
growth impress number provid guidanc
believ modest headwind tax reform
manag within syk overal financi target
acknowledg syk organ growth engin continu produc good
result see risk chang big way immedi futur
howev view growth reflect stock price
deliv upsid margin earn go along top line growth
trade ep consensu expect ep growth
next two year rais pt base
ep think fair multipl premium
grower note stock trade valu prior target
base prior ep expect also high
equal good risk-reward level view remain uw
segment detail segment ortho sale xfx
organ vs consensu medsurg revenu xfx
organ vs consensu neuro spine revenu mm
xfx organ vs consensu mm us sale
ou sale xfx
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
underweight seen ortho busi
outperform peer recent solid result
medsurg howev valuat high rel
peer group think multipl struggl
increas see risk becom
competit
improv ortho volum share take
help new product strong hospit capit
consolid ortho help price use
weaker util core hip knee market
share loss core market price pressur
slowdown medsurg growth mako fail
ramp fx lack leverag regain
share bundl challeng cjr
growthbarclay consensusy/yxfxtot mm except ep actualbarclay consensu mm except updat increas increas increas profit gross flow ebitda profit ebit incom tax tax rate incom net average share ep increas ep increas ep cont increas barclay corp
matthew taylor cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/static/ researchdissemin html order access barclay research conflict manag polici
statement pleas refer http //publicresearch barcap com/static/ conflictmanag html
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market
